Ubs Group Ag Comera Life Sciences Holdings, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.29 - $0.68 $1,846 - $4,328	6,366 Added 385.58%	8,017 $2,000
Q2 2023 Aug 11, 2023	SELL	$0.4 - $0.89 $163 - $363	-408 Reduced 19.82%	1,651 $0
Q1 2023 May 12, 2023	BUY	$0.84 - $1.9 $693 - $1,569	826 Added 66.99%	2,059 $1,000
Q4 2022 Feb 08, 2023	SELL	$1.2 - $1.93 $1,672 - $2,690	-1,394 Reduced 53.06%	1,233 $1,000
Q3 2022 Nov 10, 2022	SELL	$0.09 - $4.01 $48 - $2,145	-535 Reduced 16.92%	2,627 $4,000
Q2 2022 Aug 10, 2022	BUY	$1.17 - $14.25 $3,699 - $45,058	3,162 New	3,162 $8,000

Ticker CMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,087,200
Description
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.